Illumina, Inc. (NASDAQ:ILMN) and Pacific Biosciences of California, Inc. (NASDAQ:PACB) today announced that they have mutually agreed to terminate their merger agreement, previously announced on November 1, 2018, under which Illumina would acquire Pacific Biosciences at a fully diluted enterprise value of approximately $1.2 billion in an all-cash transaction. Considering the … [Read more...] about Illumina and Pacific Biosciences Announce Termination of Merger Agreement
- Skip to main content
- Skip to secondary menu
- Skip to primary sidebar
- Skip to secondary sidebar
- Skip to footer
Market Intelligence
Footer
OPINT
- North Korea is working to create a nuclear warfighting capability
- China’s proliferation of nuclear and missile-related technologies to other countries
- The United States has been a major supporter of Ukraine’s security
- The Impact of the Middle East on Global Geopolitics
- The Impact of the Belt and Road Initiative on Global Geopolitics